Financial Summary (All financials)
In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 200.0 | 188.5 | 171.7 | 140.7 | 0.0 |
Revenue growth | 6.1% | 9.8% | 22.0% | 937580.0% | |
Cost of goods sold | 88.1 | 72.5 | 61.9 | 50.7 | 0.0 |
Gross profit | 111.9 | 115.9 | 109.8 | 89.9 | 0.0 |
Gross margin | 56.0% | 61.5% | 63.9% | 63.9% | 60.0% |
Sales and marketing | 62.6 | 58.0 | 55.8 | 50.7 | 0.0 |
Research and development | | | | 12.6 | 0.0 |
General and administrative | 19.6 | 22.8 | 18.3 | 21.7 | 0.0 |
EBITA | -126.9 | -98.6 | 8.9 | -2.4 | 7.1 |
EBITA margin | -63.5% | -52.3% | 5.2% | -1.7% | 47613.3% |
Amortization of intangibles | 15.1 | 15.6 | 15.8 | 15.4 | 7.1 |
EBIT | -142.0 | -114.2 | -6.8 | -17.8 | 0.0 |
EBIT margin | -71.0% | -60.6% | -4.0% | -12.6% | 20.0% |
Pre-tax income | -142.9 | -115.4 | -6.9 | -248.6 | -0.1 |
Income taxes | -6.0 | -1.0 | -2.2 | -10.4 | 0.1 |
Tax rate | 4.2% | 0.9% | 31.6% | 4.2% | |
Net income | -136.9 | -114.3 | -4.7 | -238.2 | -0.1 |
Net margin | -68.5% | -60.7% | -2.7% | -169.4% | -653.3% |
|
Diluted EPS | ($4.63) | ($3.76) | ($0.15) | ($7.84) | |
Shares outstanding (diluted) | 29.6 | 30.4 | 30.4 | 30.4 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|